Navigation
Trademark Information
Application ID
Status
Date of Application
08 December 2022
Classes
5
Attorney
Innovative Consultants[21461]
A 4/501, Vaishnavi Park, Shankar Pawshe Road, Kailash Nagar, Kalyan East, Kalyan, Thane, Maharashtra 421306
Type
Device
State
Maharashtra
Country
Filing Mode
e-Filing
IP Office
MUMBAI
Used Since
Valid / Upto
Description
[Class : 5] Pharmaceuticals Preparations And Substances Used For The Treatment Of Bacterial Infections.
Image (DEVICE)
Documents
| Examination Report |
Uploaded Documents
| 1 | TM-A(TRADE MARKS APPLICATION) | 08 Dec 2022 |
| 2 | Reply to Exam Report (MIS-R) | 29 Jul 2023 |
| 3 | TM-O(NOTICE OF OPPOSITION) | 29 Jul 2024 |
| 4 | Journal Copy | 06 Aug 2024 |
| 5 | TM-O(NOTICE OF OPPOSITION) | 17 Aug 2024 |
| 6 | TM-O(NOTICE OF OPPOSITION) | 26 Aug 2024 |
Correspondence and Notices
| 1 | EXAMINATION REPORT | 15468929 | 21 Jun 2023 | |
| 2 | Hearing Notice (Show Cause) | 17687665 | 11 Mar 2024 | |
| 3 | Tribunal Accepted Notice for : 5713757 | 18052178 | 6711150 | 27 Apr 2024 |
| 4 | Opposition Notice | 18923001 | 6924198 | 30 Sep 2024 |
| 5 | Opposition Notice | 18923026 | 6924202 | 30 Sep 2024 |
| 6 | Opposition Notice | 18923146 | 6924232 | 30 Sep 2024 |
Frequently Asked Questions
What is the application date as per IP India website?
As per IP India data the trademark was applied on 08 December 2022.
Who has filed the trademark application with the TMO?
BLISS GVS PHARMA applied for Clindacin ovules.
What is the listed class of the Clindacin ovules with IP India?
Listed class of trademark Clindacin ovules is 5.
As per IP india what is the stage of trademark application?
Clindacin ovules is on the Opposed stage of the trademark process.
What is the Serial number provided by the trademark data?
Serial Number provided to trademark application is 5713757
Who filed the trademark on behalf of the proprietor?
Trademark application was filed by the following attorney agent:
Innovative Consultants
How is the Clindacin ovules categorized?
The trademark is categorized as DEVICE.